Cite
HARVARD Citation
Gambella, M. et al. (2019). Minimal residual disease by flow cytometry and allelic‐specific oligonucleotide real‐time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis. Cancer. 125 (5), pp. 750-760. [Online].